168 related articles for article (PubMed ID: 24088121)
21. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
Holbrook AM
Ann Intern Med; 2023 Jun; 176(6):JC70. PubMed ID: 37276599
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
23. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
Zhang Z; Wu Y; Tan NC; Jiang Y
Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
[TBL] [Abstract][Full Text] [Related]
24. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
Hachad H; Ramsey LB; Scott SA
Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
[No Abstract] [Full Text] [Related]
25. Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes.
Samwald M; Adlassnig KP
J Am Med Inform Assoc; 2013 May; 20(3):409-12. PubMed ID: 23345409
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
Daneshjou R; Huddart R; Klein TE; Altman RB
Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
[TBL] [Abstract][Full Text] [Related]
27. Implementation of pharmacogenomics in product information.
Skvrce NM; Krivokapić S; Božina N
Pharmacogenomics; 2020 May; 21(7):443-448. PubMed ID: 32336208
[No Abstract] [Full Text] [Related]
28. Doubt about the feasibility of preemptive genotyping.
Koch BC; van Schaik RH; van Gelder T; Mathijssen RH;
Clin Pharmacol Ther; 2013 Mar; 93(3):233. PubMed ID: 23232547
[No Abstract] [Full Text] [Related]
29. Response to "Doubt about the feasibility of preemptive genotyping".
Denny JC; Schildcrout JS; Pulley JM; Roden DM
Clin Pharmacol Ther; 2013 Mar; 93(3):234. PubMed ID: 23249779
[No Abstract] [Full Text] [Related]
30. DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.
Dalabira E; Viennas E; Daki E; Komianou A; Bartsakoulia M; Poulas K; Katsila T; Tzimas G; Patrinos GP
Public Health Genomics; 2014; 17(5-6):265-71. PubMed ID: 25228099
[TBL] [Abstract][Full Text] [Related]
31. Introduction to the theme "Precision medicine and prediction in pharmacology".
Insel PA; Amara SG; Blaschke TF
Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
[No Abstract] [Full Text] [Related]
32. [Pharmacogenetics and prediction of side effects of drugs].
Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
[TBL] [Abstract][Full Text] [Related]
33. Whole-genome sequencing in pharmacogenetics.
Urban TJ
Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
[No Abstract] [Full Text] [Related]
34. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
Hizel HC
Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
[No Abstract] [Full Text] [Related]
35. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
Pilotto A; Panza F; Seripa D
Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics and adverse drug reactions.
Meyer UA
Lancet; 2000 Nov; 356(9242):1667-71. PubMed ID: 11089838
[TBL] [Abstract][Full Text] [Related]
37. [Ethics on genetic research (1). Pharmacogenetic studies].
Ayuso C; Abad-Santos F; Dal-Ré R; Gracia D
Med Clin (Barc); 2011 May; 136(15):678-82. PubMed ID: 20044101
[No Abstract] [Full Text] [Related]
38. The future of pharmacogenetics in the treatment of migraine.
Borro M; Guglielmetti M; Simmaco M; Martelletti P; Gentile G
Pharmacogenomics; 2019 Nov; 20(16):1159-1173. PubMed ID: 31637960
[TBL] [Abstract][Full Text] [Related]
39. Strategies for Avoiding Benzopyrone Hepatotoxicity in Lymphedema Management-The Role of Pharmacogenetics, Metabolic Enzyme Gene Identification, and Patient Selection.
Hu M; Piller NB
Lymphat Res Biol; 2017 Dec; 15(4):317-323. PubMed ID: 29087786
[TBL] [Abstract][Full Text] [Related]
40. Genetics and variable drug response.
Wilke RA; Dolan ME
JAMA; 2011 Jul; 306(3):306-7. PubMed ID: 21771992
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
